CXLUSA
- Country
- 🇺🇸United States
- Ownership
- Private
- Established
- 2009-01-01
- Employees
- -
- Market Cap
- -
- Website
- http://www.cxlusa.com
Clinical Trials
7
Trial Phases
2 Phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (3 trials with phase data)• Click on a phase to view related trials
Collagen Cross-Linking With Ultraviolet-A in Asymmetric Corneas
- Conditions
- Eye DiseasesKeratoconusCorneal DiseasesPhotosensitizing Agents
- First Posted Date
- 2017-01-24
- Last Posted Date
- 2022-01-12
- Lead Sponsor
- Cxlusa
- Target Recruit Count
- 2228
- Registration Number
- NCT03029104
- Locations
- 🇺🇸
Schwartz Laser Eye Center, Scottsdale, Arizona, United States
🇺🇸Goodman Eye Center, San Francisco, California, United States
🇺🇸Cornea Consultants of Colorado, Littleton, Colorado, United States
CXL-04 A Study of Collagen Crosslinking With Ultraviolet-A in Asymmetric Corneas
- Conditions
- Keratoconus
- First Posted Date
- 2013-10-08
- Last Posted Date
- 2018-10-12
- Lead Sponsor
- Cxlusa
- Target Recruit Count
- 1324
- Registration Number
- NCT01956474
- Locations
- 🇺🇸
Center for Excellence in Eye Care, Miami, Florida, United States
🇺🇸Stulting Research Center at Woolfson Eye Institute, Atlanta, Georgia, United States
🇺🇸TLC Laser Eye Center, Fairfax, Virginia, United States
Ultraviolet-A and Riboflavin Treatment for Infectious Keratitis
- Conditions
- Infectious Keratitis
- First Posted Date
- 2012-12-03
- Last Posted Date
- 2018-09-26
- Lead Sponsor
- Cxlusa
- Target Recruit Count
- 13
- Registration Number
- NCT01739673
- Locations
- 🇺🇸
Schwartz Laser Eye Center, Scottsdale, Arizona, United States
🇺🇸Davidorf Eye Group, West Hills, California, United States
🇺🇸Corneal Consultants of Colorado, PC, Littleton, Colorado, United States
Combined CXL//UV and PRK or LASIK in Forme Fruste Keratoconus or Eyes With Potential Risk of Ectasia
- Conditions
- Fruste KeratoconusRisk of Ectasia
- Interventions
- Device: Corneal Cross-Linking
- First Posted Date
- 2012-11-14
- Last Posted Date
- 2015-08-24
- Lead Sponsor
- Cxlusa
- Target Recruit Count
- 22
- Registration Number
- NCT01726283
- Locations
- 🇺🇸
Schwartz Laser Eye Center, Scottsdale, Arizona, United States
🇺🇸Clear View Eye & Laser Medical Center, San Diego, California, United States
🇺🇸The Center for Excellence in Eye Care, Miami, Florida, United States
Cross-linking of Corneal Collagen (CXL) With Ultraviolet-A in Asymmetric Corneas
- Conditions
- KeratoconusEctasiaDegeneration
- Interventions
- Drug: Ciprofloxicin or Vigamox or other.Drug: Steroid (FML, Pred Forte, Flarex, etc.)Drug: Nonsteroidal (Acular, Acuvail, Voltaren Xibrom, etc)
- First Posted Date
- 2010-08-27
- Last Posted Date
- 2018-10-12
- Lead Sponsor
- Cxlusa
- Target Recruit Count
- 3493
- Registration Number
- NCT01189864
- Locations
- 🇺🇸
Schwartz Laser Eye Center, Scottsdale, Arizona, United States
🇺🇸Harvard Eye Associates, Laguna Hills, California, United States
🇺🇸Clear View Eye & Laser Medical Center, San Diego, California, United States
- Prev
- 1
- 2
- Next